MILLS ROBERT S 4
4 · TFF Pharmaceuticals, Inc. · Filed Aug 15, 2023
Insider Transaction Report
Form 4
MILLS ROBERT S
Director
Transactions
- Purchase
Common Stock
2023-08-15$0.25/sh+40,000$10,000→ 55,980 total
Footnotes (1)
- [F1]Acquired from the Issuer pursuant to the public offering described in the Issuer's Prospectus filed with the U.S. Securities and Exchange Commission on August 14, 2023.